Lu Z, Du W, Jiao X, Wang Y, et al. NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial. J Clin Oncol 2025 Apr 3:JCO2401818. doi: 10.1200/JCO-24-01818.
PMID: 40179324